Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 383

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Outcomes of transcatheter mitral valve replacement for degenerated bioprostheses, failed annuloplasty rings, and mitral annular calcification

Yoon, Sung-Han, Whisenant, Brian K, Bleiziffer, Sabine, Delgado, Victoria, Dhoble, Abhijeet, Schofer, Niklas, Eschenbach, Lena, Bansal, Eric, Murdoch, Dale J, Ancona, Marco, Schmidt, Tobias, Yzeiraj, Ermela, Vincent, Flavien, Niikura, Hiroki, Kim, Won-Keun, Asami, Masahiko, Unbehaun, Axel, Hirji, Sameer, Fujita, Buntaro, Silaschi, Miriam, Tang, Gilbert H L, Kuwata, Shingo, Wong, S Chiu, Frangieh, Antonio H, Barker, Colin M, Davies, James E, Lauten, Alexander, Deuschl, Florian, Nombela-Franco, Luis, Rampat, Rajiv, Nicz, Pedro Felipe Gomes, Masson, Jean-Bernard, Wijeysundera, Harindra C, Sievert, Horst, Blackman, Daniel J, Gutierrez-Ibanes, Enrique, Sugiyama, Daisuke, Chakravarty, Tarun, Hildick-Smith, David, de Brito, Fabio Sandoli, Jensen, Christoph, Jung, Christian, Smalling, Richard W, Arnold, Martin, Redwood, Simon, Kasel, Albert Markus, Maisano, Francesco, Treede, Hendrik, Ensminger, Stephan M, Kar, Saibal, Kaneko, Tsuyoshi, Pilgrim, Thomas, Sorajja, Paul, Van Belle, Eric, Prendergast, Bernard D, Bapat, Vinayak, Modine, Thomas, Schofer, Joachim, Frerker, Christian, Kempfert, Joerg, Attizzani, Guilherme F, Latib, Azeem, Schaefer, Ulrich, Webb, John G, Bax, Jeroen J, Makkar, Raj R·2019·European Heart Journal

Abstract

Aims: We sought to evaluate the outcomes of transcatheter mitral valve replacement (TMVR) for patients with degenerated bioprostheses [valve-in-valve (ViV)], failed annuloplasty rings [valve-in-ring (ViR)], and severe mitral annular calcification [valve-in-mitral annular calcification (ViMAC)]. Methods and results: From the TMVR multicentre registry, procedural and clinical outcomes of ViV, ViR, and ViMAC were compared according to Mitral Valve Academic Research Consortium (MVARC) criteria. A total of 521 patients with mean Society of Thoracic Surgeons score of 9.0 ± 7.0% underwent TMVR (322 patients with ViV, 141 with ViR, and 58 with ViMAC). Trans-septal access and the Sapien valves were used in 39.5% and 90.0%, respectively. Overall technical success was excellent at 87.1%. However, left ventricular outflow tract obstruction occurred more frequently after ViMAC compared with ViR and ViV (39.7% vs. 5.0% vs. 2.2%; P < 0.001), whereas second valve implantation was more frequent in ViR compared with ViMAC and ViV (12.1% vs. 5.2% vs. 2.5%; P < 0.001). Accordingly, technical success rate was higher after ViV compared with ViR and ViMAC (94.4% vs. 80.9% vs. 62.1%; P < 0.001). Compared with ViMAC and ViV groups, ViR group had more frequent post-procedural mitral regurgitation ≥moderate (18.4% vs. 13.8% vs. 5.6%; P < 0.001) and subsequent paravalvular leak closure (7.8% vs. 0.0% vs. 2.2%; P = 0.006). All-cause mortality was higher after ViMAC compared with ViR and ViV at 30 days (34.5% vs. 9.9% vs. 6.2%; log-rank P < 0.001) and 1 year (62.8% vs. 30.6% vs. 14.0%; log-rank P < 0.001). On multivariable analysis, patients with failed annuloplasty rings and severe MAC were at increased risk of mortality after TMVR [ViR vs. ViV, hazard ratio (HR) 1.99, 95% confidence interval (CI) 1.27-3.12; P = 0.003; ViMAC vs. ViV, HR 5.29, 95% CI 3.29-8.51; P < 0.001]. Conclusion: The TMVR provided excellent outcomes for patients with degenerated bioprostheses despite high surgical risk. However, ViR and ViMAC were associated with higher rates of adverse events and mid-term mortality compared with ViV.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/eurheartj/ehy590

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 22 references

Cited by

See all 383

Metadata

Authors
Yoon, S.-H., Whisenant, B. K., Bleiziffer, S., Delgado, V., Dhoble, A., Schofer, N., Eschenbach, L., Bansal, E., Murdoch, D. J., Ancona, M., Schmidt, T., Yzeiraj, E., Vincent, F., Niikura, H., Kim, W.-K., Asami, M., Unbehaun, A., Hirji, S., Fujita, B., Silaschi, M., Tang, G. H. L., Kuwata, S., Wong, S. C., Frangieh, A. H., Barker, C. M., Davies, J. E., Lauten, A., Deuschl, F., Nombela-Franco, L., Rampat, R., Nicz, P. F. G., Masson, J.-B., Wijeysundera, H. C., Sievert, H., Blackman, D. J., Gutierrez-Ibanes, E., Sugiyama, D., Chakravarty, T., Hildick-Smith, D., de Brito, F. S., Jensen, C., Jung, C., Smalling, R. W., Arnold, M., Redwood, S., Kasel, A. M., Maisano, F., Treede, H., Ensminger, S. M., Kar, S., Kaneko, T., Pilgrim, T., Sorajja, P., Van Belle, E., Prendergast, B. D., Bapat, V., Modine, T., Schofer, J., Frerker, C., Kempfert, J., Attizzani, G. F., Latib, A., Schaefer, U., Webb, J. G., Bax, J. J., & Makkar, R. R.
Venue
European Heart Journal
Published
2018-10-23
Volume
40
Issue
5
Pages
441-451
ISSN
  • 0195-668X (ISSN-L)
  • 1522-9645
OpenAlex
W2898581089
Cited by
383
References
22
FWCI
30.45
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Outcomes of transcatheter mitral valve replacement for degenerated bioprostheses, failed annuloplasty rings, and mitral annular calcification. https://app.cochat.ai/papers/10.1093/eurheartj/ehy590
The paper
Yoon, S.-H., Whisenant, B. K., Bleiziffer, S., Delgado, V., Dhoble, A., Schofer, N., Eschenbach, L., Bansal, E., Murdoch, D. J., Ancona, M., Schmidt, T., Yzeiraj, E., Vincent, F., Niikura, H., Kim, W.-K., Asami, M., Unbehaun, A., Hirji, S., Fujita, B., . . . Makkar, R. R. (2019). Outcomes of transcatheter mitral valve replacement for degenerated bioprostheses, failed annuloplasty rings, and mitral annular calcification. European Heart Journal. https://doi.org/10.1093/eurheartj/ehy590

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.